Jeffrey R. Schriber, MD, FRCP, discusses some of the available treatment options for patients with multiple myeloma and how the treatment landscape has evolved over time.
Jeffrey R. Schriber, MD, FRCP
Jeffrey R. Schriber, MD, FRCP is the director of hematologic malignancies at Cancer Treatment Centers of America (CTCA) in Phoenix, Arizona.
Articles by Jeffrey R. Schriber, MD, FRCP
New studies have shown promise for updated standards of care in patients with lymphoma.
Latest Updated Articles
World Lymphoma Day: Advances in Therapy Signal A New Standard of Care for Patients with Hodgkin or Non-Hodgkin LymphomaPublished: September 15th 2022 | Updated: